Professional Documents
Culture Documents
Chemotherapy Part 2
Chemotherapy Part 2
Vinca Alkaloids
- Binds to microtubules and inhibit mitotic
spindle formation
- Resistance occurs by acquisition of
multidrug resistance phenotype or
development of microtubules with
decreased vinca alkaloid binding
1.
2.
-
Vincristine
Administered intravenously
Metabolized in the liver= 70%
BHL, HL, ALL, MM, Ewings sarcoma,
Wilms tumor, rhabdomyosarcoma
Dose limiting toxicity: neurotoxicity
(paresthesia of the fingers and lower legs,
loss of deep-tendon reflexes
Constipation is common
Cranial nerve palsies, ataxia, seizure,
coma
Bone marrow suppression is not common
Vinblastine
Alkaloid derived from Vinca rosea
Metablized by the liver P450 system
Majority of the drug excreted in the feces
via the hepatobiliary system
Potent vesicant
Adverse effect: nausea, vomiting, bone
marrow suppression, alopecia
HL, NHL, Breast cancer
Antitumor Antibiotics
1. Anthracyclines
2. Doxorubicin
3. Daunorubicin
4. Idarubicin
5. Epirubicin
6. Mitoxantrone
Main dose-limiting toxicity of all
anthracyclines: